IMMUNIC, INC. — Director's Dealing 2021

Mar 15, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2021-03-10

Reporting Person: Muehler Andreas (Chief Medical Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	284480	Indirect
Common Stock	10006	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$15.72	2031-03-01	Common Stock (65000)		Direct
Stock Option	$12.30	2030-07-01	Common Stock (44000)		Direct
Stock Option	$13.34	2029-08-12	Common Stock (10000)		Direct
Stock Option	$13.29	2029-08-01	Common Stock (30000)		Direct

Footnotes

F1: The Reporting Person is Director of Xanomed GmbH, which is the record holder of 284,480 shares of common stock of the Issuer, and exercises voting and dispositive power over such shares.

F2: 16,250 of the shares underlying the option vest on the first anniversary of the grant date. Thereafter, 1,360 of the underlying shares vest on the thirteen month anniversary of the grant date and 1,354 of the underlying shares vest on each successive one-month anniversary thereafter for the next 35 months.

F3: 11,000 of the shares underlying the option vest on the first anniversary of the grant date. Thereafter, 940 of the underlying shares vest on the thirteen month anniversary of the grant date and 916 of the underlying shares vest on each successive one-month anniversary thereafter for the next 35 months.

F4: 2,500 of the shares underlying the option vest on the first anniversary of the grant date. Thereafter, 220 of the underlying shares vest on the thirteen month anniversary of the grant date and 208 of the underlying shares vest on each successive one-month anniversary thereafter for the next 35 months.

F5: 7,500 of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months.